Review Article
Renal Denervation for Treating Resistant Hypertension: Current Evidence and Future Insights from a Global Perspective
| Improper blood pressure measurement | Associated conditions |
| Volume overload and pseudotolerance | (i) Obesity | (i) Excess sodium intake | (ii) Excess alcohol intake | (ii) Volume retention from kidney disease | (iii) Physical inactivity | | (iv) Low-fiber diet |
| Drug-induced or other causes | Secondary causes of RH |
| (i) Nonadherence | (i) Obstructive sleep apnea | (ii) Inadequate doses | (ii) Primary aldosteronism | (iii) Inappropriate combinations | (iii) Pheochromocytoma | (iv) Cyclosporine and tacrolimus | (iv) Hyperparathyroidism | (v) Cocaine, amphetamines, and other illicit drugs | (v) Aortic coarctation | (vi) Sympathomimetics (decongestants, anorectics) | (vi) Renal parenchymal disease | (vii) Herbal compounds | (vii) Renal artery stenosis | (viii) Adrenal steroids | (viii) Intracranial tumor | (ix) Nonsteroidal anti-inflammatory drugs; aspirin, cyclooxygenase 2 inhibitors | | (x) Erythropoietin | | (xi) Licorice (including some chewing tobacco) | | (xii) Oral contraceptives | |
|
|